Docoh
Loading...

54 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q2
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
Note 11 – Related Party Transactions A shareholder, CorLyst, LLC, reimburses us for shared costs related to payroll, health care insurance and rent
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
, government or government agency programs, trade customers, managed health care organizations and pharmacy benefit managers (or equivalents thereof
10-Q
2021 Q1
PCSA Processa Pharmaceuticals Inc
13 May 21
Quarterly report
4:30pm
A shareholder, CorLyst, LLC, reimburses us for shared costs related to payroll, health care insurance and rent based on actual costs incurred, which
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the ACA), provides … health care programs. The Medicaid Drug Rebate Program requires pharmaceutical manufacturers to enter into and have in effect a national rebate agreement
D
PCSA Processa Pharmaceuticals Inc
19 Feb 21
$10.24M in equity / options, sold $10.24M, 18 investors
9:26am
Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals Other … Health Care Manufacturing Real Estate Commercial Construction REITS & Finance Residential Other Real Estate Retailing Restaurants Technology
10-Q
roobjto
12 Nov 20
Quarterly report
4:01pm
8-K
EX-99.1
1uzzfe
5 Nov 20
Processa Pharmaceuticals Announces the Appointment of
9:00am
8-K
EX-1.1
s9qpwzwjx5gsvnf
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
mk0j352ya sp
5 Oct 20
Prospectus supplement with pricing info
4:16pm
S-1/A
3u4f8mndcf0b
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
9v7 oe5kh5dq0d7nk
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-1.1
p6d933j eb2doqb4s
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.13
wdrmqz0mz2xoasmafy
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.11
6k70vqhdwevyv4ks4v
16 Sep 20
IPO registration (amended)
8:00pm
8-K
EX-10.1
5enl5mhg5
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
g6pjs2
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
10-Q
utuhkk3
5 Aug 20
Quarterly report
3:32pm
S-1/A
i67v6a r5ox
17 Jul 20
IPO registration (amended)
5:25pm
10-Q
7x00v5j6uk
15 May 20
Quarterly report
1:23pm
10-K
zwxmagogjtx4po
5 Mar 20
Annual report
7:00pm